Health Canada drug identification number

DIN 02506211 — HERZUMA 150 MG

HERZUMA is a powder for solution of Trastuzumab marketed by CELLTRION INC.. The full Trastuzumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02506211
Brand name
HERZUMA
Active ingredient
Trastuzumab
Strength
150 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
CELLTRION INC.
Health Canada status
MARKETED
Drug class
Antineoplastic (HER2-targeted monoclonal antibody)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Trastuzumab products

DINBrandStrengthFormManufacturerStatus
02240692 HERCEPTIN 440 MG POWDER FOR SOLUTION HOFFMANN-LA ROCHE LIMITED MARKETED
02480697 HERCEPTIN SC 600 MG SOLUTION HOFFMANN-LA ROCHE LIMITED MARKETED
02480794 HERZUMA 440 MG KIT; POWDER FOR SOLUTION CELLTRION INC. MARKETED
02518244 KANJINTI 150 MG POWDER FOR SOLUTION AMGEN CANADA INC MARKETED
02496690 KANJINTI 420 MG KIT; POWDER FOR SOLUTION AMGEN CANADA INC MARKETED
02474425 OGIVRI 150 MG POWDER FOR SOLUTION BIOSIMILAR COLLABORATIONS IRELAND LIMITED MARKETED
02524317 ONTRUZANT 150 MG POWDER FOR SOLUTION SAMSUNG BIOEPIS CO., LTD MARKETED
02524325 ONTRUZANT 440 MG POWDER FOR SOLUTION SAMSUNG BIOEPIS CO., LTD MARKETED
02483475 TRAZIMERA 150 MG POWDER FOR SOLUTION PFIZER CANADA ULC MARKETED
02483467 TRAZIMERA 440 MG POWDER FOR SOLUTION PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.